Many provinces and cities will further reduce the price of pilot drugs to follow up the procurement of drugs with quantity.

　　The expansion of the pilot procurement with quantity has gradually become clear. On July 1st, Hebei Province officially followed up the pilot project of centralized drug procurement and use organized by the state. Hebei Province estimated the basic purchasing quantity of selected drugs with 60% of the total drug consumption of public medical institutions in the province in 2018, and implemented quantity procurement, quantity-price linkage and quantity-for-price exchange.

　　According to the reporter’s incomplete statistics of the Economic Information Daily, up to now, Fujian, Qinghai, Hebei, Shandong, Taiyuan, Wuxi and other provinces and cities have joined the procurement camp with quantity except Beijing, Shanghai and Chongqing. Among them, Fujian, Hebei and Qinghai have been officially launched, and Jiangxi, Shandong, Liaoning, Inner Mongolia, Taiyuan, Wuxi and other provinces and cities have started to find out the quantity of purchased varieties.

　　The Implementation Plan of Hebei Province for Follow-up Implementation of the Pilot Work of Centralized Procurement and Use of Drugs Organized by the State, issued by Hebei Province, shows that the drug price will be significantly reduced, the burden of patients’ drug costs will be reduced, the transaction costs of enterprises will be reduced, the circulation environment will be purified, the industry ecology will be improved, medical institutions will be guided to standardize drug use, and the reform of public medical institutions will be supported.

　　Xu Jianpei, deputy governor of Hebei Province, said at the "video conference on the mobilization and deployment of the pilot work of centralized drug procurement and use organized by the state in the whole province" that Hebei Province will organize procurement in a unified manner according to the successful results of centralized drug procurement and supporting measures in Beijing and Tianjin; Each co-ordination area specifically implements the procurement quantity and settlement funds of public medical institutions within its jurisdiction; Public medical institutions at all levels complete the procurement task in the provincial drug procurement platform.

　　Specifically, the relevant departments of Shandong Province jointly issued a notice requesting public medical institutions in the province to report the data on the use of drugs selected in the national centralized drug procurement and use pilot, which was regarded by the outside world as a clear signal that Shandong Province would follow up the procurement with quantity.

　　It is reported that in April this year, the two departments of Jiangxi Province issued a document requesting all public medical institutions in the province to fill in the annual planned purchase volume of the selected varieties in 25 countries. In Shandong, it is required to count the usage of related varieties in 2017 and 2018 before July 1, and the predicted usage from October 1, 2019 to September 30, 2020. In principle, it is not lower than the average usage in 2017 and 2018. It is worth noting that the amount of procurement required to be reported in Shandong Province includes primary medical institutions such as township hospitals and community health centers.

　　In Inner Mongolia, relevant documents show that it is planned to select four cities as pilots to carry out price linkage work with quantity and settlement for selected drugs in "4+7" national quantity procurement. In order to ensure the accuracy of dosage, it is necessary to count the actual procurement volume of hospitals in 2018 and the planned procurement volume in 2019. At the same time, Wuxi and Taiyuan all showed that it was required to find out the amount of drugs purchased with quantity.

　　"Multiple non-‘ 4+7’ The provinces and cities took the initiative to follow up, and the comprehensive procurement with quantity was unstoppable. " According to industry insiders, from the previous landing situation of 4+7 pilot cities such as Xiamen and Shanghai, the overall progress of the pilot procurement with quantity exceeded expectations, which is also the main factor for the expansion of the pilot procurement with quantity.

　　Chen Jinfu, deputy director of the National Health Insurance Bureau, said at the routine briefing on the State Council policy held on April 16th that as of April 1st, 11 pilot cities had been fully launched, and by 24: 00 on April 14th, the total purchase of 25 selected varieties in 11 pilot areas had reached 438 million tablets/piece, accounting for 27.31% of the total agreed purchase, and the progress of the "4+7" drug centralized procurement pilot exceeded expectations.

　　According to reports, from the pilot effect, patients with major diseases such as cancer, hepatitis B, hypertension and mental illness in the pilot area have obtained high-quality and low-cost drugs, and the medical expenses have dropped significantly. Take Entecavir dispersible tablets, a generic antiviral drug for hepatitis B, as an example. The selected price is 17.36 yuan/box (28 tablets/box), a decrease of 93%. If patients use this selected drug instead of the original drug (7 tablets are 175.68 yuan/box), the annual drug cost will be reduced from about 9,000 yuan to about 200 yuan, which greatly reduces the burden of patients with hepatitis B.

　　Xiamen related data also show that after two months of the pilot, as of May 15th, the total purchase quantity of 25 selected varieties was 12.67 million (pieces/piece), and 59% of the agreed purchase quantity in this region has been completed, and the agreed purchase quantity has been completed well. In terms of guaranteed payment, the average payment period is 28 days; In terms of supply guarantee, the average inventory of distribution enterprises can meet the clinical needs of 146 days, all of them can respond to orders within 12 hours and distribute the selected drugs to medical institutions within 24 hours; In terms of quality assurance, Fujian provincial and municipal drug supervision departments found no unqualified drugs during the quality inspection of selected drugs, and no abnormal risk signals of adverse reactions were found in 25 selected drugs.

　　Some insiders said that in recent years, the relevant departments have effectively reduced the price of drugs and reduced the burden of drug use for patients in China, which is the main force of the policy in recent years. Under the background that the pilot results exceed expectations, it is expected that the expansion of the pilot areas and the scope of pilot drugs will be accelerated.

　　"At the same time as the pilot of quantity procurement is expanded, increasing the intensity of negotiations will also become another key to reducing drug prices." The above-mentioned people said that China is about to start negotiations on the access to the drug list, and the price of drugs will be effectively reduced by means of market exchange.

　　The above-mentioned person said that the regulator will gain the absolute initiative in the next stage of procurement negotiations with quantity, so that the bargaining target will be more efficient and it is easy to obtain lower prices.